GMED250117P90000
- 6.78
- -0.72-9.60%
Globus Medical Newsroom
RBC Capital Maintains Globus Medical(GMED.US) With Buy Rating, Raises Target Price to $101
Piper Sandler Maintains Globus Medical(GMED.US) With Buy Rating, Maintains Target Price $100
Piper Sandler Reaffirms Their Buy Rating on Globus Medical (GMED)
Truist Financial Maintains Globus Medical(GMED.US) With Hold Rating, Raises Target Price to $90
RBC Raises Price Target on Globus Medical to $101 From $92, Keeps Outperform Rating
Roth MKM Maintains Globus Medical(GMED.US) With Buy Rating, Raises Target Price to $115
BTIG Maintains Globus Medical(GMED.US) With Buy Rating, Maintains Target Price $91
Globus Medical Analyst Ratings
Jefferies Maintains Globus Medical(GMED.US) With Buy Rating, Raises Target Price to $100
Jefferies Maintains Globus Medical(GMED.US) With Buy Rating, Raises Target Price to $100
Globus Medical (GMED) Gets a Buy From Jefferies
CCORF Maintains Globus Medical(GMED.US) With Buy Rating, Maintains Target Price $92
BTIG Maintains Globus Medical(GMED.US) With Buy Rating, Raises Target Price to $91
Globus Medical Is Maintained at Overweight by Wells Fargo
Wells Fargo Maintains Globus Medical(GMED.US) With Buy Rating, Raises Target Price to $95
Wells Fargo Reaffirms Their Buy Rating on Globus Medical (GMED)
Globus Medical Analyst Ratings
Canaccord Genuity Maintains Buy on Globus Medical, Raises Price Target to $92
CCORF Maintains Globus Medical(GMED.US) With Buy Rating, Raises Target Price to $92
Globus Medical Raised to Overweight From Equal-Weight by Morgan Stanley